- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07013903
- Original Trial
Effects of Hydrotherapy During Post-COVID-19 Rehabilitation (HydroCoVital A)
Effects of Kneipp Hydrotherapy During Inpatient Post-Covid-19 Rehabilitation: A Randomized Controlled Trial
Study Overview
Status
Intervention / Treatment
Detailed Description
Patients recovering from Post-COVID Syndrome often experience persistent fatigue, autonomic dysregulation, microcirculatory disturbances, and low-grade inflammation, all of which may hinder their return to full function. Kneipp hydrotherapy-using cold water applications-can address these pathophysiological changes through several mechanisms:
Autonomic regulation: Cold stimuli trigger parasympathetic activation and improve sympathovagal balance, helping to stabilize heart rate variability and reduce symptoms of dysautonomia often seen in Post-COVID.
Enhanced microcirculation: Repeated vasoconstriction and reactive vasodilation promote endothelial function and tissue perfusion, which may alleviate muscle aches, dizziness, and fatigue by improving oxygen and nutrient delivery.
Anti-inflammatory effects: Hydrothermal stimuli have been shown to modulate cytokine profiles, increasing anti-inflammatory mediators and potentially dampening the persistent, low-grade inflammation implicated in Post-COVID pathophysiology.
Musculoskeletal recovery: Thermo-mechanical stimulation relaxes tense muscle fibers, reduces pain perception, and supports gradual increases in physical capacity, all of which are important for overcoming Post-COVID deconditioning.
Taken together, these effects suggest that adjunctive cold water hydrotherapy could accelerate functional recovery, reduce symptom burden, and enhance quality of life in Post-COVID rehabilitation.
Baseline Assessments:
At baseline, demographic data including sex, age, height, and weight will be collected. Participants will report their current main Post-COVID symptoms, which will be categorized into symptom clusters: Fatigue (A), Cognitive (B), and Somatic (C). Smoking history will be assessed, including smoking status (current, former, or never), number of cigarettes per day, years of smoking, and pack-years.
The time (in months) since the COVID-19 infection that led to Post-COVID syndrome will be documented, along with the number of COVID-19 vaccinations received at the time of infection. Employment status will be recorded, distinguishing between full-time or part-time employment, COVID-related work disability, retirement, unemployment, or disability pension.
Comorbidities will be documented across the following categories: cardiovascular, pulmonary, cerebrovascular, metabolic, musculoskeletal, psychiatric, and other conditions. The severity of the acute COVID-19 illness will be assessed using the WHO Clinical Progression Scale, including information on any hospital admission and length of stay (in days).
Pulmonary function testing at baseline (V1) will include FEV₁, FVC, FEV₁/FVC ratio, and total lung capacity (TLC), all expressed as percent predicted. Autonomic function will be evaluated using the Schellong test. Vascular status will be assessed by four-limb blood pressure measurement. Additionally, self-reported work ability and the number of Post-COVID-related sick leave days within the past 12 weeks will be recorded.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Rainer Gloeckl, PhD
- Phone Number: +498652931630
- Email: rgloeckl@schoen-klinik.de
Study Locations
-
-
Bavaria
-
Schönau am Königssee, Bavaria, Germany, 83471
- Recruiting
- Schön Klinik Berchtesgadener Land
-
Contact:
- Rainer Gloeckl, PhD
- Phone Number: +498652931630
- Email: rgloeckl@schoen-klinik.de
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosis of Post-COVID Syndrome (ICD-10 code: U08.9)
- Barthel-Index >80
- Referred to the reference center for Post-COVID rehabilitation
- Owning a smartphone to receive digital questionnaires and to use the measurement app for heart rate variability
- Written informed consent
Exclusion Criteria:
- Existing contraindications for Kneipp hydrotherapy like severe cardiovascular diseases (e.g., decompensated heart failure, unstable angina pectoris, acute myocardial infarction), severe venous diseases (e.g., acute deep vein thrombosis of the leg), severe neurological diseases (e.g., uncontrolled epilepsy)
- Prior regular practice of Kneipp applications
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Post-COVID Rehabilitation with hydrotherapy
Cold water hydrotherapy (5-10 minutes each), twice daily during the 3-week multimodal inpatient rehabilitation program and once daily during the 6-month follow-up period
|
Cold water hydrotherapy (5-10 minutes each), twice daily during the 3-week multimodal inpatient rehabilitation program and once daily during the 6-month follow-up period
|
|
Active Comparator: Post-COVID Rehabilitation without hydrotherapy
3-week inpatient multimodal inpatient rehabilitation program without hydrotherapy
|
same rehabilitation program than the experimental group but without hydrotherapy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Health-related quality of life by Short Form-12 Health Survey (SF-12)
Time Frame: From baseline (Visit 1) to end of inpatient rehabilitation (3 weeks, Visit 2)
|
Change in the Short Form-12 physical and mental component summary scores
|
From baseline (Visit 1) to end of inpatient rehabilitation (3 weeks, Visit 2)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fatigue severity by Fatigue Severity Scale
Time Frame: From baseline (Visit 1) to end of inpatient rehabilitation (3 weeks, Visit 2)
|
Change in Fatigue Severity Scale score
|
From baseline (Visit 1) to end of inpatient rehabilitation (3 weeks, Visit 2)
|
|
Sleep quality by Pittsburgh Sleep Quality Index
Time Frame: From baseline (Visit 1) to end of inpatient rehabilitation (3 weeks, Visit 2)
|
Change in Pittsburgh Sleep Quality Index score
|
From baseline (Visit 1) to end of inpatient rehabilitation (3 weeks, Visit 2)
|
|
Health status by EuroQol-5 Dimensions-5 Levels
Time Frame: From baseline (Visit 1) to end of inpatient rehabilitation (3 weeks, Visit 2)
|
Change in EuroQol-5 Dimensions-5 Levels questionnaire score
|
From baseline (Visit 1) to end of inpatient rehabilitation (3 weeks, Visit 2)
|
|
Autonomic function (heart rate variability by photoplethysmography)
Time Frame: Daily during first 3 weeks of rehabilitation (Visit 1 to Visit 2)
|
Change in heart rate variability (root mean square of successive differences) measured by Kyto 2935 via photoplethysmography
|
Daily during first 3 weeks of rehabilitation (Visit 1 to Visit 2)
|
|
Resting blood pressure (systolic and diastolic)
Time Frame: Daily during first 3 weeks of rehabilitation (Visit 1 to Visit 2)
|
Change in morning resting systolic and diastolic blood pressure
|
Daily during first 3 weeks of rehabilitation (Visit 1 to Visit 2)
|
|
Post-COVID work-absence days
Time Frame: From baseline (Visit 1) to 3 months (Visit 3) and to 6 months (Visit 4)
|
Number of days of work absence due to Post-COVID-19 symptoms during the past 12-weeks
|
From baseline (Visit 1) to 3 months (Visit 3) and to 6 months (Visit 4)
|
|
Long-term quality of life by Short Form-12
Time Frame: From baseline (Visit 1) to 3 months (Visit 3) and to 6 months (Visit 4)
|
Change in Short Form-12 scores at follow-up
|
From baseline (Visit 1) to 3 months (Visit 3) and to 6 months (Visit 4)
|
|
Long-term fatigue by Fatigue Severity Scale
Time Frame: From baseline (Visit 1) to 3 months (Visit 3) and to 6 months (Visit 4)
|
Change in Fatigue Severity Scale score at follow-up
|
From baseline (Visit 1) to 3 months (Visit 3) and to 6 months (Visit 4)
|
|
Adherence to hydrotherapy
Time Frame: During the 3-week intervention phase (up to Visit 2) and over the 6-month follow-up period (to Visit 4)
|
Proportion of prescribed hydrotherapy applications in the intervention group performed, as recorded in diary or app. Short-term Adherence: During the 3-week intervention phase, patients are considered "adherent" if they perform at least one hydrotherapy session per day on at least 75% of study days. We will compare health improvements between high-adherence and low-adherence participants. Long-term Adherence and Effects: Over the 3- and 6-month follow-up, "adherent" patients are those who continue self-administered hydrotherapy at least four times per week on at least 75% of follow-up weeks. We will assess whether these patients sustain greater gains in quality of life. |
During the 3-week intervention phase (up to Visit 2) and over the 6-month follow-up period (to Visit 4)
|
|
Adverse events recording
Time Frame: From start of intervention (Visit 1) through end of study (Visit 4, 6-month follow-up)
|
Number and severity of adverse events related to Kneipp hydrotherapy
|
From start of intervention (Visit 1) through end of study (Visit 4, 6-month follow-up)
|
|
Long-term heart rate variability changes (HRV)
Time Frame: From baseline (Visit 1) to 3 months (Visit 3) and to 6 months (Visit 4)
|
Change in heart rate variability parameters (root mean square of successive differences) measured by photoplethysmography.
At follow-up visits patients will measure HRV for 7 consecutive days
|
From baseline (Visit 1) to 3 months (Visit 3) and to 6 months (Visit 4)
|
|
Post-exertional malaise severity
Time Frame: From baseline (Visit 1) to 6-month (Visit 4) follow-up
|
Change in Post-Exertional Malaise score measured by the DePaul Symptom Questionnaire-Post-Exertional Malaise
|
From baseline (Visit 1) to 6-month (Visit 4) follow-up
|
|
Daily well-being documentation
Time Frame: Daily throughout the intervention and 6 months follow-up phase (Visit 1 to Visit 4)
|
Self-reported daily well-being recorded via digital diary on a scale from 0 to 100
|
Daily throughout the intervention and 6 months follow-up phase (Visit 1 to Visit 4)
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Rembert Koczulla, MD, Schön Klinik Berchtesgadener Land
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Post-Infectious Disorders
- COVID-19
- Pathologic Processes
- Chronic Disease
- Disease Attributes
- Respiratory Tract Infections
- Infections
- RNA Virus Infections
- Virus Diseases
- Respiratory Tract Diseases
- Lung Diseases
- Pneumonia, Viral
- Pneumonia
- Coronavirus Infections
- Coronaviridae Infections
- Nidovirales Infections
- Pathological Conditions, Signs and Symptoms
- Post-Acute COVID-19 Syndrome
Other Study ID Numbers
- HydroCoVital A
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post COVID Syndrome
-
Lawson Research Institute of St. Joseph'sCanadian Institutes of Health Research (CIHR); Western University, CanadaRecruitingFatigue | Post-COVID-19 Syndrome | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19 | Long-COVID | Post-COVID ConditionCanada
-
Erasmus Medical CenterDa Vinci Clinic; HGC RijswijkNot yet recruitingPost-COVID-19 Syndrome | Long COVID | Long Covid19 | Post COVID-19 Condition | Post-COVID Syndrome | Post COVID-19 Condition, Unspecified | Post-COVID ConditionNetherlands
-
RSUP PersahabatanCompletedPost COVID-19 Syndrome | Long COVID-19 Syndrome | Post COVID Syndrome Long CovidIndonesia
-
Universidad Rey Juan CarlosNot yet recruitingPost COVID Syndrome | Long Covid | Long COVID Fatigue | Post COVID Syndrome Long Covid
-
Eggensberger OHGBavarian Health and Food Safety Authority (LGL)RecruitingPost COVID-19 Condition | Post COVID-19 | Post COVID-19 Syndrome | Long COVID-19 Syndrome | Post COVID-19 Condition (PCC)Germany
-
Medical University of ViennaRecruitingVagus Nerve Diseases | Post-COVID-19 Syndrome | Long COVID | Long Covid19 | Post COVID-19 Condition | Post-COVID Syndrome | Post COVID ConditionAustria
-
StemCyte, Inc.Not yet recruitingLong COVID | Post-COVID Syndrome | Post-COVID-19 Condition | Post-COVID Condition
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecruitingLong COVID | Post COVID Syndrome | Long COVID-19 Syndrome | Long COVID SyndromeNetherlands
-
StemCyte, Inc.AvailableLong COVID | Post-COVID Syndrome | Chronic Fatigue | Post-COVID-19 Condition | Fatigue Post Viral | Post-COVID Condition | Chronic Fatigue SymptomsUnited States
-
Karolinska University HospitalKarolinska Institutet; The Swedish Research Council; Region Stockholm; Swedish... and other collaboratorsCompletedCOVID-19 | Post COVID-19 Condition | Post-COVID Syndrome | Post COVID-19 Condition, Unspecified | Post COVID Condition | Post-Acute COVID-19 SyndromeSweden
Clinical Trials on Standard rehabilitation plus cold water hydrotherapy
-
Eggensberger OHGBavarian Health and Food Safety Authority (LGL)RecruitingPost COVID-19 Condition | Post COVID-19 | Post COVID-19 Syndrome | Long COVID-19 Syndrome | Post COVID-19 Condition (PCC)Germany
-
AspetarNot yet recruitingMuscle Tear | Hamstring Muscles | Hamstring Muscle Repair | Hamstring Rupture | Hamstring InjuriesQatar
-
University of North Carolina, GreensboroCompleted
-
Istanbul Arel UniversityKayseri UniversityNot yet recruiting
-
Gaziosmanpasa Research and Education HospitalRecruitingSarcopenia | Sarcopenia in ElderlyTurkey (Türkiye)
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
University of EdinburghCompletedChronic Low Back Pain (Non-specific, Uncomplicated)United Kingdom
-
Istanbul University - Cerrahpasa (IUC)CompletedPain, Postoperative | Elbow Fracture | Upper Extremity Problem | Limitation, MobilityTurkey
-
Zhejiang Cancer HospitalNot yet recruiting
-
Parc de Salut MarCompletedKnee OsteoarthritisSpain